Organogenesis Holdings Inc. Annual Income Tax Expense (Benefit) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Organogenesis Holdings Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
  • Organogenesis Holdings Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $2.5M, a 35.2% decline year-over-year.
  • Organogenesis Holdings Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $3.5M, a 21.7% decline year-over-year.
  • Organogenesis Holdings Inc. annual Income Tax Expense (Benefit) for 2023 was $5.45M, a 14.7% increase from 2022.
  • Organogenesis Holdings Inc. annual Income Tax Expense (Benefit) for 2022 was $4.75M.
  • Organogenesis Holdings Inc. annual Income Tax Expense (Benefit) for 2021 was -$31.1M, a 5971% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.45M +$697K +14.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $4.75M +$35.9M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$31.1M -$31.6M -5971% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $530K +$380K +253% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $150K +$66K +78.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $84K +$7.11M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-16
2017 -$7.03M -$7.09M -10908% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-09
2016 $65K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.